Company news

Arecor Therapeutics PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Second Price Monitoring Extn

March 13, 2023

Arecor to present sharesoc webinar

March 1, 2023

Arecor Granted Patents in India and the US

February 16, 2023

Arecor strengthens collaboration with partner

February 14, 2023

Arecor Publishes Data for AT278 in Diabetes Care

January 30, 2023

Business update

January 19, 2023

Arecor announces transfer of AT307 to Hikma

January 12, 2023

Tetris pharma launches Ogluo® in Austria

January 4, 2023

Tetris pharma service agreement with Syneos Health

December 12, 2022

Grant of LTIP Options and PDMR Dealing

December 6, 2022

Arecor to commence second trial with AT278

November 22, 2022

Arecogranted patent in Japan and South Korea

November 22, 2022

Grant of AESOP Options and PDMR Dealing

November 17, 2022

Arecor Therapeutics scientist hopeful that arti...

November 15, 2022

Specialty hospital formulation collaboration

November 10, 2022

Exercise of options and PDMR dealing

November 8, 2022

Tetris pharma launches Ogluo® in Germany

November 1, 2022

Headline results from Phase I trial of AT247

October 11, 2022

Arecor Presents Positive Data for AT278 at EASD

September 20, 2022

Interim Results for six months ended 30 June 2022

September 8, 2022

Arecor granted European patents

August 9, 2022

Director/PDMR Dealings

August 4, 2022

Result of Placing

August 1, 2022

Proposed Acquisition of Tetris Pharma Ltd

August 1, 2022

Arecor announces presentation at EASD 2022

July 4, 2022

Arecor collaborates with top global pharma company

June 16, 2022

Result of agm

May 23, 2022

Arecor AGM statement

May 23, 2022

Arecor to host kol webinar

May 18, 2022

Arecor presents AT278 Phase I data at ATTD meeting

April 28, 2022

Arecor 2021 annual report and notice of AGM

April 27, 2022

Final results for the year ended 31 December 2021

April 25, 2022

Arecor announces oral presentation at ATTD 2022

April 12, 2022

Notice of Preliminary Results

March 29, 2022

Arecor wins at CambridgeshireLive Business Awards

March 28, 2022

Arecor provides business update

January 20, 2022

Arecor commences US Phase I trial of AT247

January 20, 2022

Arecor Provides Update on Agreement with Hikma

December 21, 2021

Arecor Collaborates with Global Technology Leader

December 14, 2021

Grant of Options, PDMR Dealing

November 25, 2021

Holdings in Company

November 11, 2021

Arecor Granted Key Canadian Patent

November 11, 2021

Arecor announces formulation study collaboration

November 1, 2021

Exercise of options, PDMR, Total Voting Rights

October 25, 2021

Arecor's Polysaccharide Vaccine Patent Upheld

October 11, 2021

Interim results for six months ended 30 June 2021

September 23, 2021

Positive results for AT278 clinical trial

September 20, 2021

FDA clearance of IND

September 9, 2021

Exclusive collaboration with intas pharmaceuticals

September 7, 2021

Appointment of grant thornton as auditor

August 27, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 11 decks. Every deck is listed under its year.